A VentureBeat article talks about the recent funding surge for biotech firms and medical device companies this year. While funding is still at a six-year high, it dropped 19 percent this quarter to $1.1 billion, compared to the same period last year when biotech investment reached $1.8 billion, more than double what the industry raised a year earlier.